Vulvovaginal Candidiasis: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 1, 2019
May 6, 2020
3c14a50c-15d0-4ad3-94ec-76a32afa2bdb
Related Documents
Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry
Guidance DocumentNovember 18, 2019Center for Drug Evaluation and Research
Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.